Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 667 clinical trials
Optimal Detection of Atrial Fibrillation in TIA (ODEA-TIA)

Transient ischemic attack (TIA) is a common neurologic emergency. Although the detection of atrial fibrillation (AF) has identical consequences for preventive therapy in patients with ischemic

brain infarction
transient ischemic attack
electrocardiogram
infarct
cardiac monitoring
  • 0 views
  • 27 Feb, 2022
  • 2 locations
Cardiovascular Risk Reduction in Atrial Fibrillation Trial

Atrial fibrillation (AF) is a serious public health problem because of its increasing incidence and prevalence in the aging population. AF is associated with elevated risks of death, stroke

ejection fraction
transient ischemic attack
persistent atrial fibrillation
acute coronary syndrome
myocardial infarction
  • 0 views
  • 25 Jun, 2021
Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events (AF-SPICE)

Stroke is one of the leading causes behind death and permanent disability in adults. Atrial fibrillation (AF) is the most common clinical arrhythmia and its prevalence is steeply increasing with

  • 0 views
  • 21 Mar, 2022
  • 1 location
Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial

Introduction: Patients with atrial fibrillation (AF) have a substantial risk of stroke and systemic embolism. Subclinical AF is often suspected to be the cause of stroke in these patients. The

cardiac resynchronization therapy
anticoagulation therapy
anticoagulant therapy
infarct
embolism
  • 0 views
  • 11 Sep, 2021
  • 1 location
Dabigatran for Mitral Stenosis Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrythmia encountered in clinical practice and patients suffer from this are at increased risk of ischemic stroke and systemic

  • 0 views
  • 28 Jan, 2021
  • 1 location
The South-Norway Atrial Fibrillation Screening Study

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder. The most serious common complication of AF is ischemic stroke.The aim of this study is to investigate the yield of

  • 0 views
  • 27 Jan, 2021
  • 1 location
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF RCT)

addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).

pulmonary vein isolation
persistent atrial fibrillation
catheter ablation
electrocardiogram
arrhythmia
  • 28 views
  • 14 Feb, 2022
  • 13 locations
Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation (ASPIRIN-LAAO)

appendage occlusion (LAAO). Patients diagnosed with atrial fibrillation and have undergone LAAO will be enrolled in this study. Randomization will be performed at 6 months post-implant. The

aspirin
acute coronary syndrome
left atrial appendage occlusion
vascular disease
embolism
  • 14 views
  • 09 Feb, 2022
  • 1 location
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)

Atrial fibrillation (AF) is the most common form of irregular heart rhythm. In people with AF, blood clots often form in the heart, which can travel to the brain. Blockage of brain arteries by

edoxaban
rivaroxaban
apixaban oral tablet
anticoagulants
apixaban
  • 16 views
  • 11 Feb, 2022
  • 16 locations
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) (ENRICH-AF)

ischemic, hemorrhagic and unspecified stroke) in high-risk atrial fibrillation (CHA2DS2-VASc 2) patients with previous intracranial hemorrhage.

edoxaban
atrial fibrillation
vascular disease
stroke
anticoagulants
  • 15 views
  • 16 Feb, 2022
  • 139 locations